tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DAWN Stock Latest News

Buy Rating Affirmed for Day One Biopharmaceuticals Based on Promising Long-Term Data from FIREFLY-1 Trial
RatingsBuy Rating Affirmed for Day One Biopharmaceuticals Based on Promising Long-Term Data from FIREFLY-1 Trial
9d ago
DAWN
Day One Biopharmaceuticals Reveals Promising Phase 2 Trial Results
PremiumCompany Announcements
Day One Biopharmaceuticals Reveals Promising Phase 2 Trial Results
10d ago
8K
DAWN
Buy Rating Affirmed for Day One Biopharmaceuticals: Promising FIREFLY-1 Trial Results and Ojemda’s Market Potential
PremiumRatings
Buy Rating Affirmed for Day One Biopharmaceuticals: Promising FIREFLY-1 Trial Results and Ojemda’s Market Potential
10d ago
DAWN
Promising Clinical Results and Growth Potential Reinforce Buy Rating for Day One Biopharmaceuticals’ Ojemda
PremiumRatings
Promising Clinical Results and Growth Potential Reinforce Buy Rating for Day One Biopharmaceuticals’ Ojemda
10d ago
DAWN
Day One Biopharmaceuticals announces three-year follow-up data from FIREFLY-1
PremiumThe Fly
Day One Biopharmaceuticals announces three-year follow-up data from FIREFLY-1
10d ago
DAWN
Strategic Acquisition of Mersana Therapeutics Boosts Day One Biopharmaceuticals’ Market Potential: Buy Rating Affirmed
PremiumRatingsStrategic Acquisition of Mersana Therapeutics Boosts Day One Biopharmaceuticals’ Market Potential: Buy Rating Affirmed
20d ago
DAWN
Strategic Acquisition and Promising Drug Pipeline Drive Buy Rating for Day One Biopharmaceuticals
Premium
Ratings
Strategic Acquisition and Promising Drug Pipeline Drive Buy Rating for Day One Biopharmaceuticals
21d ago
DAWN
Strategic Acquisition of Mersana by Day One: Enhancing Pipeline and Growth Prospects
Premium
Ratings
Strategic Acquisition of Mersana by Day One: Enhancing Pipeline and Growth Prospects
21d ago
DAWN
Oppenheimer says Day One paying up to $285M for Mersana ‘is interesting’
PremiumThe Fly
Oppenheimer says Day One paying up to $285M for Mersana ‘is interesting’
21d ago
DAWN
MRSN
Strategic Acquisition of Mersana Therapeutics Boosts Day One Biopharmaceuticals’ Oncology Pipeline
PremiumRatings
Strategic Acquisition of Mersana Therapeutics Boosts Day One Biopharmaceuticals’ Oncology Pipeline
21d ago
DAWN
Why Is Mersana Therapeutics Stock (MRSN) Up Today?
PremiumMarket News
Why Is Mersana Therapeutics Stock (MRSN) Up Today?
21d ago
DAWN
MRSN
Day One Biopharmaceuticals Announces Mersana Acquisition Deal
PremiumCompany Announcements
Day One Biopharmaceuticals Announces Mersana Acquisition Deal
21d ago
8K
DAWN
Day One Biopharmaceuticals to acquire Mersana Therapeutics for up to $285M
PremiumThe FlyDay One Biopharmaceuticals to acquire Mersana Therapeutics for up to $285M
21d ago
DAWN
MRSN
Day One Biopharmaceuticals to acquire Mersana Therapeutics for up to $285M
Premium
The Fly
Day One Biopharmaceuticals to acquire Mersana Therapeutics for up to $285M
21d ago
DAWN
MRSN
Day One Biopharmaceuticals price target raised to $27 from $26 at JPMorgan
Premium
The Fly
Day One Biopharmaceuticals price target raised to $27 from $26 at JPMorgan
27d ago
DAWN
Day One Biopharma’s Positive Q3 Earnings Call
PremiumCompany Announcements
Day One Biopharma’s Positive Q3 Earnings Call
28d ago
DAWN
Strong Buy Recommendation for Day One Biopharmaceuticals Driven by Robust Financial Performance and Promising Drug Efficacy
PremiumRatings
Strong Buy Recommendation for Day One Biopharmaceuticals Driven by Robust Financial Performance and Promising Drug Efficacy
29d ago
DAWN
Positive Outlook for Day One Biopharmaceuticals: Strong Q3 Performance and Upgraded Guidance Justify Buy Rating
PremiumRatings
Positive Outlook for Day One Biopharmaceuticals: Strong Q3 Performance and Upgraded Guidance Justify Buy Rating
29d ago
DAWN
Day One Biopharmaceuticals price target raised to $26 from $25 at Piper Sandler
PremiumThe Fly
Day One Biopharmaceuticals price target raised to $26 from $25 at Piper Sandler
29d ago
DAWN
Day One Biopharmaceuticals Reports Strong Q3 2025 Growth
PremiumCompany AnnouncementsDay One Biopharmaceuticals Reports Strong Q3 2025 Growth
29d ago
DAWN
Day One Biopharmaceuticals Reports Strong Q3 2025 Results
Premium
Company Announcements
Day One Biopharmaceuticals Reports Strong Q3 2025 Results
29d ago
8K
DAWN
Day One Biopharmaceuticals reports Q3 EPS (19c), consensus (28c)
Premium
The Fly
Day One Biopharmaceuticals reports Q3 EPS (19c), consensus (28c)
30d ago
DAWN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >